Healthcare

Newsom wants California, home to nearly 40 million people, to contract with generic drug companies to make prescription medications on its behalf so it could then sell them to the public. The goal, according to the governor's office, is to lower prices by increasing competition in the generic market.

The U.S. Food and Drug Administration approved an ovarian cancer drug for the maintenance and treatment of pancreatic cancer, according to AstraZeneca and Merck.

Some deadly diseases that seemed headed for eradication in recent decades have been making a scary comeback in the past 10 years.

Officials say the wrong person was given a kidney transplant at Virtua Our Lady of Lourdes Hospital in Camden, New Jersey. 

Ubrogepant, a new class of drug to treat acute migraine attacks, shows promise to treat patients who have previously lacked other options.

A simple blood test may be capable of predicting breast cancer risk in women several years before clinical signs begin to appear, according to a promising study out of Nottingham University’s School of Medicine.

Novartis, a Swiss pharmaceutical company, halted worldwide distribution of its generic version of the popular heartburn medication Zantac after the U.S. Food and Drug Administration found traces of a possible carcinogen in it.

A 24-year-old woman with heart failure who has been denied a third transplant is asking for help in completing a bucket list as her family prepares for the worst.

A 77-year-old Washington man and his 76-year-old wife were found dead a “likely murder-suicide,” as notes were left on the scene about concerns over their high medical bills, according to police.